Lab21 is expanding its clinical diagnostics portfolio with the introduction of a new service to identify the two most common causes of fungal pneumonia. The CE-marked FXGTM:RESP (ASP+) test, developed by UK diagnostics company Myconostica, will identify infections caused by Aspergillus and Pneumocystis, which account for over 95% of cases of fungal pneumonia and could radically alter the diagnosis of fungal disease.
Benson Viscometers Ltd is a British manufacturing company that specialises in the design, development and manufacture of high quality plasma viscometers and blood measuring equipment.
Established in 1999 the family run company has established itself as the leader in the provision of Plasma Viscometers throughout the UK. The majority of the...
Online
13-14 January, 2026
The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026
Grand Hotel, Birmingham
10 - 11 February, 2026
10 Union Street, London, SE1 1SZ
2 March, 2026
Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026
